Get complete Patent Opposition Report for Kandy Therapeutics

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Kandy Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3765024Nov 22, 2023Novel Pharmaceutical Formulation Comprising Dual Nk-1/Nk-3 Receptor Antagonists1
EP3574907Aug 23, 2023An Nk-1/Nk-3 Receptor Antagonist For The Treatment Of Sex-Hormone-Dependent Diseases1